Gabelli Growth Innovators ETF (ARCA: GGRW)

Gabelli Growth Innovators ETF (ARCA:GGRW), Trade Ideas

Gabelli Growth Innovators ETF

A criminal trial against former President Donald Trump kicked off Monday, April 15 with jury selection and an outline of what's to come<a href="https://www.benzinga.com/general/politics/24/04/38261008/donald-trump-argues-political-prosecution-before-jury-selection-in-new-york-trial-judge-not-goin"> for the case.</a>
On Tuesday, the jury selection process continued and the social media accounts of prospective candidates took center stage.
What Happened: On Tuesday, the first seven jurors in the criminal trial against Trump were chosen, as part of the process<a href="https://www.benzinga.com/general/politics/24/04/38251447/trump-hush-money-trial-preview-key-witnesses-2024-campaign-impact-prison-time-trump-could-face-i"> that will decide</a> if the former president is guilty of alleged hush money payments to adult actress Stormy Daniels.
Judge Juan Merchan swore in the jurors who passed the approval process as part of a lengthy process that saw dozens of potential candidates rejected based on not being able to be impartial in the trial or for old social media posts and follows revealed in court, as <a href="https://www.nbcnews.com/politics/donald-trump/live-blog/-trump-hush-money-trial-day-2-live-updates-rcna145935">reported </a>by NBC News.
The jurors were told to return on Monday, April 22 at 9:30 a.m. ET with Merchan assuming the full jury will be selected by then. A total of 18 approved jurors is needed for the case with 12 jurors and six alternates.  
While names and ages are not public, court reporters have provided brief descriptions of the seven jurors, which are as follows:
Male: works as a waiter and in sales, likes the outdoors, gets his news from The New York Times, Fox News and MSNBC
Female: works as oncology nurse, engaged and enjoys spending time with family and friends, gets her news from The New York Times, CNN, Google and Facebook
Male: works as an attorney, likes to run and hike, gets news from The New York Times, Google and The Wall Street Journal
Male: works in IT training and consulting, married and has grandchildren, gets news from New York Daily News, New York Times, Google and X
Female: teacher, likes to travel, gets news from TikTok and Google
Female: software engineer, gets news from The New York Times, Facebook, TikTok and Google
Gender not revealed at press time: North Carolina-born attorney is a civil litigator, lives on the Upper East Side and listens to &#8220;Car Talk.&#8221;
Merchan also brought in another group of 96 potential jurors who will return to court to resume the jury selection process at 9:30 a.m. ET Thursday. The potential jurors were told not to discuss the case with anyone or to read news related to the case.
Related Link: <a href="https://www.benzinga.com/general/politics/24/04/38279176/trump-hush-money-trial-draws-reaction-from-congressman-talk-show-hosts-worse-than-anything-richa">Trump Hush Money Trial Draws Reaction From Congressman, Talk Show Hosts: &#8216;Worse Than Anything Richard Nixon Ever Did&#8217;</a>
Social Media Takes Center Stage: A large number of potential jurors said they get their news from various social media platforms such as Meta Platforms Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>)-owned Facebook, TikTok and X, formerly known as Twitter and owned by Elon Musk.
While potential jurors were asked where they get their news from, past postings on social media also came into play by lawyers in the case when deciding who could be impartial in the trial against Trump.
Trump lawyer Todd Blanche challenged several potential jurors about posts on social media.
"Trump indicted in documents case, No one is above the law," were comments made by a potential juror on social media that Blanche shared in court. Merchan struck the juror candidate for cause.
Another juror was questioned over an anti-Trump post made by her husband on social media in 2015. Merchan allowed the juror to stay in the process and told Blanche that jurors need to be asked if they can be fair and impartial instead of digging up old posts.
There were old posts that did lead to dismissal though, including a 2017 Facebook post made by a potential juror against Trump.
"Good news!! Trump lost his court battle on his unlawful travel ban!!!. Get him out and lock him up," the 2017 post read.
One social media post became a controversial topic over what was meant.
"I have to get in the car and spread the honking cheers. There's an actual party on 96th Street," the person posted.
Blanche took exception as the post was made the Saturday after the 2020 presidential election, which saw Joe Biden defeat Trump. Blanche told Merchan that the posts showed the juror expressing their opinion about Trump, which led to additional clarification by the juror.
"I think I was going to my car for alternate side of the street parking. And there were people honking in the street," the potential juror said comparing the event to people cheering for health care workers during the COVID-19 pandemic.
This potential juror exchange led to the X account EndWokeness <a href="https://twitter.com/EndWokeness/status/1780313481926864987">posting </a>that the "juror who joined a Biden election victory parade is NOT qualified off the jury against Trump."
"The reason? Because the juror claims she thought it was a celebration of essential workers…." the X account said.
The post generated a response from Elon Musk, who replied, "This doesn't seem just."
Social media was the star of the second day of the trial and could be the star again on Thursday as more old social media posts by potential jurors are found. The trial could serve as a reminder that old posts on social media don't disappear and could someday be made public again.
Read Next:&nbsp;<a href="https://www.benzinga.com/general/politics/24/04/38193809/stormy-daniels-former-lawyer-michael-avenatti-gives-prison-interview-ahead-of-hush-money-trial-t" target="_blank" rel="noreferrer noopener">Stormy Daniels' Former Lawyer Michael Avenatti Gives Prison Interview Ahead Of Hush Money Trial: Trump ‘Will Be Convicted'</a>
Image created with artificial intelligence on MidJourney using a Zolnierek photo from Shutterstock.

Social Media

Politics

Legal

Trump Trial Gets 7 Jurors, 11 To Go: Their Old Social Media Posts Take Center Stage In Court, Elon Musk Questions Why One Juror Can Stay

Equity Bancshares (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EQBK#NYSE">EQBK</a>) reported quarterly earnings of $0.90 per share which beat the analyst consensus estimate of $0.85 by 5.88 percent. This is a 16.88 percent increase over earnings of $0.77 per share from the same period last year. The company reported quarterly sales of $55.91 million which beat the analyst consensus estimate of $52.81 million by 5.88 percent. This is a 16.00 percent increase over sales of $48.20 million the same period last year.

Earnings

News

EQBK

Equity Bancshares Q1 EPS $0.90 Beats $0.85 Estimate, Sales $55.91M Beat $52.81M Estimate

Sunoco has priced at&nbsp;100%&nbsp;a private offering of&nbsp;7.000%&nbsp;senior notes due 2029 in an aggregate principal amount of&nbsp;$750 million and&nbsp;7.250%&nbsp;senior notes due 2032 in an aggregate principal amount of&nbsp;$750 million. The sale of the notes is expected to settle on&nbsp;April 30, 2024.

Offerings

Sunoco LP Reports Pricing Of Private Offering Of Senior Notes

Under the strategic partnership between Teva and Alvotech, Teva is responsible for the exclusive commercialization of SELARSDI in the United States.&nbsp;FDA&nbsp;has approved SELARSDI (ustekinumab-aekn) injection for subcutaneous use, as a biosimilar to Stelara, for the treatment of moderate to severe plaque psoriasis and for active psoriatic arthritis in adults and pediatric patients 6 years and older.&nbsp;

ALVO

TEVA

Alvotech, Teva Announce US FDA Approval Of SELARSDI, Biosimilar To Stelara

Trade Desk (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTD#NASDAQ">TTD</a>) has outperformed the market over the past 5 years by 19.58% on an annualized basis producing an average annual return of 31.23%. Currently, Trade Desk has a market capitalization of $40.08 billion. 
Buying $1000 In TTD: If an investor had bought $1000 of TTD stock 5 years ago, it would be worth $3,891.86 today based on a price of $82.00 for TTD at the time of writing.
<h3>Trade Desk's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1713303024_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

Here's How Much You Would Have Made Owning Trade Desk Stock In The Last 5 Years

&quot;We are excited by these data and optimistic about the potential tezepelumab has for patients with COPD, a condition that continues to have a significant unmet medical need,&quot; said&nbsp;James Bradner, M.D., executive vice president of Research and Development and chief scientific officer at Amgen.&nbsp;

AMGN

Amgen Provides Update Regarding Results Of Phase 2a COURSE Trial For TEZSPIRE; Says Planning Underway For Phase 3 Development Of Tezepelumab In Chronic Obstructive Pulmonary Disease

Dubbed &#8220;the Amazon of cannabis,&#8221; the Eaze weed delivery company has grabbed headlines due to a looming <a href="https://www.ufcw770.org/770news/eaze-strike-4-2-2024">strike threat</a> from unionized workers who argue the company is not treating them fairly.
The unionized employees are considering a strike during the so-called &#8220;Pot Holiday,&#8221; a key sales day and a symbolic date for both the industry and the cannabis community as a whole. With the strategically chosen date of action, 4/20, drawing near, cannabis industry workers represented by the United Food and Commercial Workers Union (UFCW) have been called back to the negotiation table with management, as confirmed by the Union to Benzinga.
<h2 class="wp-block-heading">Pay Your Fair Share</h2>
Eaze, likely the largest of its kind, operates as a weed delivery marketplace, offering on-demand delivery to adults across California and Michigan. Since its founding in 2014, it has expanded to become a vertically integrated system selling flowers, pre-rolls, edibles, concentrates, drops, wellness products, capsules, and accessories, providing door-to-door services.
Charges have been filed against Eaze and its plant-touching subsidiary, Stachs, with the National Labor Relations Board. The complaints concern the company&#8217;s changes to drivers&#8217; mileage reimbursement and its failure to provide legally required information.
This conflict has been ongoing for months, with negotiations starting in August 2023 and pausing on March 19, 2024. Before this halt, Eaze/Stachs&#8217; final offer did not meet the workers&#8217; demands, which included increased mileage reimbursement rates, higher hourly wages, and a guarantee of a minimum number of work hours.
<h2 class="wp-block-heading">Biggest Cannabis Delivery Service Faces Challenges</h2>
According to the union, the negotiation party consists of over a dozen Eaze/Stachs employees, representing more than five hundred workers across eleven California delivery depots, including six in Southern California and five in Northern California. The union has a presence in both Northern and Southern California, including in Van Nuys, La Brea, Gardena, Silverlake, among other locations. Given these numbers, a strike during the Pot Holiday could significantly impact Eaze&#8217;s finances.
The company&#8217;s recent path has been fraught with other difficulties as well. Former CEO James Patterson pleaded guilty to one count of conspiracy to commit bank fraud amounting to<a href="https://benzinga.com/markets/cannabis/21/02/19704193/former-eaze-ceo-jim-patterson-to-be-charged-in-100m-cannabis-pay-processing-case"> $100 million in 2021</a>. Also, Eaze is currently <a href="https://www.benzinga.com/markets/cannabis/23/08/33478363/cannabis-delivery-company-faces-legal-battle-allegations-of-fraud-unlawful-operations">being sued</a> by merged associate Green Dragon. The lawsuit alleges that Eaze intentionally misled investors about its financial health and violated California law by &#8220;renting&#8221; multiple cannabis licenses to conduct its business. Also, recently, Eaze <a href="https://www.benzinga.com/markets/cannabis/24/03/38003989/eaze-cannabis-delivery-drivers-in-sacramento-join-teamsters-local-150">drivers in Sacramento</a> became members of Teamsters, meaning that the company faces unionized action on various fronts. 
As a private company, the impact of these actions on its balance sheet is not public knowledge, but management claims its current situation limits its ability to meet the union&#8217;s demands.
The outcomes of the negotiations have yet to be made public.

Cannabis

Markets

Eaze Delivery Workers Threaten First Cannabis Strike of 2024 Amid Ongoing Negotiations

The net proceeds will be used for general corporate purposes, including the repayment, redemption or refinancing of outstanding commercial paper and other near-term indebtedness.&nbsp;

Johnson Controls Reports Pricing Of Its Offering Of $700M Senior Notes Due 2029

A groundbreaking court case filed in Massachusetts against U.S. Attorney General Merrick Garland has captured the attention of the cannabis industry, promising to potentially reshape its future.
The lawsuit challenges the federal government&#39;s classification of state-legal cannabis operations as violators of the Controlled Substances Act, a status that has imposed <a href="https://www.benzinga.com/markets/cannabis/24/04/38219204/fda-commissioner-to-house-committee-theres-no-reason-for-dea-to-delay-cannabis-rescheduling">severe operational limitations</a> on these businesses. From restricting tax deductions to complicating banking relationships and stock exchange listings, the ramifications of this classification have been far-reaching.
<h3>A High-Profile Legal Battle</h3>
During the recent <a href="https://www.benzinga.com/events/cannabis-conference/?UTM_source=article">Benzinga Cannabis Capital Conference in Florida</a>, this legal challenge took center stage in a discussion led by Jason Wild, executive chairman of the multi-state cannabis operator TerrAscend, and Javier Hasse, managing director at Benzinga Cannabis.
<img alt="2231044_cccfloridagif_v2_031124-27_0.gif" src="https://www.benzinga.com/files/u503488/2231044_cccfloridagif_v2_031124-27_0.gif" style="height:528px; width:633px" />
Wild revealed the involvement of David Boies, a highly esteemed constitutional lawyer, in the case.
Reflecting on the broader implications of the lawsuit, Jason Wild also pointed out, &quot;If the David Boies case is successful, then we&#39;re told that it&#39;s a very, very short walk across the street to the<a href="https://www.benzinga.com/markets/cannabis/24/03/37915415/cannabis-businesses-face-tax-dilemma-a-closer-look-at-irs-roadblock"> IRS Tax Court</a> to get all of those taxes back. I mean, that could be many billions of dollars for the overall industry that they wouldn&#39;t have gotten back necessarily if it was just rescheduling.&quot;
<h3>David Boies: A Legal Titan Joins The Fray</h3>
Boies is renowned for his pivotal role in significant legal battles, including the legalization of same-sex marriage and the antitrust case against Microsoft. His expertise in constitutional law is expected to significantly shape the strategy and potential for <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38226873/analyst-reacts-to-fda-commish-comments-medical-and-recreational-cannabis-could-have">change in federal cannabis policy</a>. The involvement of such a notable figure underscores the case&#39;s importance and its potential ramifications for the industry.
<h3>Potential Consequences For Cannabis Taxation</h3>
A crucial aspect of this legal challenge is its implications for cannabis taxation, particularly concerning the inability of cannabis businesses to deduct operating expenses due to current federal regulations. If successful, not only could it pave the way for fairer tax treatment moving forward, but it could also allow for the retroactive recovery of <a href="https://www.benzinga.com/analyst-ratings/analyst-color/23/11/35840800/the-billion-dollar-question-how-much-are-cannabis-multi-state-operators-really-wort">billions</a> in taxes previously paid by the industry.
On taxation, Jason Wild explained the significance of the court case for cannabis businesses&#39; ability to deduct operating expenses: &quot;The argument in the complaint is that the US federal government is treating state legal cannabis operators as if they were violating the Controlled Substances Act... That&#39;s, you know, the inability to deduct your operating expenses.&quot;
<h3>A Strategic Move Toward Rescheduling</h3>
The case also intersects with the ongoing discussion about the rescheduling of cannabis. Wild highlighted how the lawsuit could apply pressure for reform across various fronts, including safe banking and executive branch rescheduling. The outcome of this case could compel Congress to act, spurred by the progress made through judicial channels.
Discussing the case&#39;s impact on cannabis scheduling and its broader implications, Wild highlighted the potential benefits of a successful outcome: &quot;If the David Boies case is successful, then we&#39;re told that it&#39;s a very, very short walk across the street to the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/23/08/33482140/rescheduling-cannabis-what-are-the-implications-for-msos-tax-rule-280e-fda-and-phar">IRS Tax Court</a> to get all of those<a href="https://www.benzinga.com/markets/cannabis/23/04/31779376/exclusive-deschedulingrescheduling-cannabis-will-it-be-an-expeditious-path-to-280e-relief-this-i"> taxes back</a>... that could be <a href="https://www.benzinga.com/analyst-ratings/analyst-color/23/08/34153665/cannabis-tax-changes-could-trigger-504-cash-flow-leap-which-industry-players-will-b">many billions of dollars for the overall industry</a> that they wouldn&#39;t have gotten back necessarily if it was just rescheduling.&quot;
This legal battle represents a strategic effort to challenge and potentially transform federal cannabis policy. With significant implications for taxation, banking, and the overall treatment of cannabis businesses, the industry watches closely, hoping for a historic change that could set a precedent for years to come.
Photo by&nbsp;<a href="https://unsplash.com/@bermixstudio?utm_content=creditCopyText&amp;utm_medium=referral&amp;utm_source=unsplash">Bermix Studio</a>&nbsp;on&nbsp;<a href="https://unsplash.com/photos/a-judges-gavel-on-top-of-a-flag-lEu6RTAajvk?utm_content=creditCopyText&amp;utm_medium=referral&amp;utm_source=unsplash">Unsplash</a>.&nbsp;

Government

Regulations

Events

Exclusives

The Court Case That Could Change The Cannabis Industry Forever And How It Affects Rescheduling

Guidance

INVO

INVO Bioscience Says It Works Toward Stated Goal Of Reaching Break-Even Or Profitability Within Its Current Operations (Excluding Potential Merger With Naya) In 2024; Says Remain On Track To Reach That Objective

TTWO

Take-Two Interactive Announced Cost Reduction Program, Expects $160M-$200M In Charges, Eliminates Projects, and Reduces Workforce By 5%; Anticipates Over $165M Annual Savings

INVO Bioscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INVO#NASDAQ">INVO</a>) reported $1.38 million in sales this quarter. This is a 396.15 percent increase over sales of $278.14 thousand the same period last year.

INVO Bioscience Q4 Sales $1.38M Up From $278.14K YoY

Top Stories for April 16, 2024:
1. Gold Resource (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GORO#NYSE">GORO</a>) reported <a href="https://www.benzinga.com/news/24/04/38263711/reported-earlier-gold-resource-preliminary-q1-results-sold-3-557-oz-of-gold-and-216-535-oz-of-silver">preliminary Q1 results</a>, including sales of 3,557 ounces of gold and 216,535 ounces of silver, totaling 5,965 gold equivalent ounces. 
The company also sold 1,682 tons of zinc, 264 tons of copper and 667 tons of lead.&nbsp;
CEO Allen Palmiere highlighted ongoing cost reduction and efficiency efforts, the progression of the 2024 drill program aimed at resource and production enhancement and beneficial effects from rising metal prices despite a strong Mexican peso.
2. Worthington Steel (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ws#NYSE">WS</a>) was recognized as a partner-level supplier for the 12th year in a row in the John Deere Achieving Excellence Program, the highest rating from Deere &amp; Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DE#NYSE">DE</a>).
Worthington Steel supplies steel sheets to multiple John Deere facilities for various agricultural equipment productions and it earned this recognition for its exceptional product quality and commitment to continuous improvement.&nbsp;
Suppliers in the John Deere Achieving Excellence Program are assessed annually on quality, delivery, process alignment, relationship and value creation.&nbsp;
Also Read:<a href="https://www.benzinga.com/topic/mining"> </a><a href="https://www.benzinga.com/m-a/24/04/38253150/gold-road-considers-major-stake-in-greenstone-investors-wary-of-potential-high-costs">Gold Road Considers Major Stake In Greenstone; Investors Wary Of Potential High Costs</a>
3. U.S. Gold (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/USAU#NASDAQ">USAU</a>) announced a $4.9 million direct offering. 
The deal includes selling 1.4 million shares at $3.50 each (total of roughly $4.9 million).
It also includes unregistered warrants to buy another 1.4 million shares at $4.48 each. The warrants are exercisable six months post-issuance and expire in five years.&nbsp;
The sale is expected to close by April 19, subject to standard conditions.
4. When asked for a comment on Ioneer's (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IONR#NASDAQ">IONR</a>) progress at its Rhyolite Ridge lithium site reported Monday, Executive Chairman James Calaway said, "The forthcoming release of the draft EIS represents six years of hard work to help build America's critical minerals supply chain and reaffirms the viability of our investment in Nevada.&#8221;
&#8220;Rhyolite Ridge will help accelerate the electric vehicle transition and secure a cleaner future for our children and grandchildren. As we move through the final steps in the federal permitting process, Ioneer will keep working to ensure this world-class project will operate efficiently and sustainably,&#8221; he added.
5. Kaiser Aluminum (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KALU#NASDAQ">KALU</a>) declared a quarterly dividend of 77 cents per share, payable on May 15 to shareholders on record as of April 25.
Now Read:<a href="https://www.benzinga.com/"> </a><a href="https://www.benzinga.com/m-a/24/04/38201281/revival-gold-acquires-ensign-minerals-to-become-a-cash-flowing-mid-tier-us-gold-producer">Revival Gold Acquires Ensign Minerals &#8216;To Become A Cash-Flowing Mid-Tier US Gold Producer&#8217;</a>
Benzinga Mining is the bridge between mining companies and retail investors. Reach out to <a href="mailto:licensing@benzinga.com">licensing@benzinga.com</a> to get connected with the Benzinga community!
Photo: Shutterstock

Commodities

Small Cap

GORO

IONR

KALU

USAU

Gold Resource Reports Q1 Sales; Worthington Steel Partner-Level Supplier; US Gold's Direct Offering And More: Tuesday's Top Mining Stories

Cannabis stocks fell in early trading before heating up Tuesday afternoon. Some of the upward momentum may be a result of executive commentary from the <a href="https://www.benzinga.com/events/cannabis-conference/" target="_blank" rel="noreferrer noopener">Benzinga Cannabis Capital Conference</a>.
Lighting Up The Cannabis Space: Several big names in the cannabis space took the stage Tuesday at Benzinga&#8217;s Cannabis Capital Conference in Hollywood, Florida, the leading cannabis investment and branding conference in North America. 
Curaleaf Hldgs Inc (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/CURLF#OTCQX">CURLF</a>) chairman&nbsp;Boris Jordan told the crowd that potential adult-use legalization in Florida isn&#8217;t the only catalyst ahead. He&#8217;s already positioning the company for similar regulation changes in other states. Curaleaf shares gained nearly 4% on Tuesday, leading the way for cannabis stocks. 
Related Link: <a href="https://www.benzinga.com/markets/cannabis/24/04/38278675/it-all-started-with-cannabis-how-this-innovative-manufacturing-software-firm-is-solving-real-pro">It All Started With Cannabis: How This Innovative Manufacturing Software Firm Is Solving &#8216;Real&#8217; Problem For Its Customers</a>
Jordan also noted that Curaleaf is seeing positive trends following cannabis legalization in Germany. In the first two weeks that cannabis was removed from the narcotics lists, there has been a five-fold increase in patients approaching telemedicine platforms, he said, suggesting cannabis demand is rising quickly.
Boris spoke around 2 p.m. ET. Curaleaf stock continued to move higher and hit the highs for the day following his appearance. Several other cannabis stocks drifted higher Tuesday afternoon. 
As previously <a href="https://www.benzinga.com/markets/cannabis/24/04/38278653/cannabis-banking-reform-closer-than-ever-d-c-insiders-tell-benzinga-conference-cannabis-etf-spik">reported by Benzinga</a>, former Congress members suggested Tuesday that regulatory changes could be coming soon that would benefit the cannabis industry as a whole. The AdvisorShares Pure US Cannabis ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSOS#NYSE">MSOS</a>) reached its lows of the day just before the former legislators took the stage at the Benzinga conference. 
Tim Seymour&#8217;s Amplify Seymour Cannabis ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNBS#NYSE">CNBS</a>) also trended higher throughout the afternoon. Seymour moderated a panel Tuesday morning that focused on cannabis valuations and investing strategies.
Benzinga&#8217;s Cannabis Capital Conference continues through Wednesday. Check out <a href="https://www.benzinga.com/events/cannabis-conference/agenda/">this page</a> for more information on upcoming speakers. 
Want to watch our Cannabis Capital Conference live? For existing subscribers, you can get <a href="https://www.benzinga.com/events/cannabis-conference/livestream/">direct access</a>. For new users, you can get <a href="https://www.benzinga.com/events/cannabis-conference/livestream/">instant access here</a>!
Cannabis Stocks Price Action: Curaleaf stock closed Tuesday up 3.31% at $4.99, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>. The AdvisorShares and Amplify Seymour Cannabis ETFs both fell in early trading before climbing back and closing the day roughly flat. 
Read Next: <a href="https://www.benzinga.com/markets/cannabis/24/04/38278562/seth-rogens-cannabis-lifestyle-brand-houseplant-available-on-instant-delivery-app-gopuff">Seth Rogen&#8217;s Cannabis &amp; Lifestyle Brand Houseplant Available On Instant Delivery App Gopuff</a>
Photo: CRYSTALWEED from Unsplash.

Equities

Movers

CNBS

CURALEAF HLDGS INC by Curaleaf Hldgs Inc.

CURLF

MSOS

Cannabis Stocks Shine As Benzinga's Cannabis Capital Conference Unfolds

CME Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) has outperformed the market over the past 20 years by 3.72% on an annualized basis producing an average annual return of 11.41%. Currently, CME Gr has a market capitalization of $74.34 billion. 
Buying $100 In CME: If an investor had bought $100 of CME stock 20 years ago, it would be worth $880.89 today based on a price of $206.48 for CME at the time of writing.
<h3>CME Gr's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1713301232_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In This Stock 20 Years Ago Would Be Worth $900 Today

MSCI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSCI#NYSE">MSCI</a>) has outperformed the market over the past 10 years by 17.92% on an annualized basis producing an average annual return of 28.28%. Currently, MSCI has a market capitalization of $40.68 billion. 
Buying $1000 In MSCI: If an investor had bought $1000 of MSCI stock 10 years ago, it would be worth $12,112.05 today based on a price of $513.43 for MSCI at the time of writing.
<h3>MSCI's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1713301227_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

MSCI

If You Invested $1000 In This Stock 10 Years Ago, You Would Have $12,000 Today

The upcoming 2024 NFL Draft serves as a reminder of the millions of dollars football players can earn, while also serving as backdrop to the issue of professional athletes needing to be <a href="https://www.benzinga.com/nfldraft/">smart with their money.</a>
Benzinga is hosting the <a href="https://www.benzinga.com/2024-nfl-draft-detroit-event-speakers-and-more/">Sports Business Titans event </a>on April 25 in <a href="https://www.benzinga.com/detroit-draft-interactive-map-things-to-do/">downtown Detroit</a>. The event will feature athletes, social media stars and business leaders who will provide a behind-the-scenes look at how sports and business often intersect.
Here are seven current and former Detroit Lions and a look at the non-NFL investments they made.
Rob Sims: A speaker at the 2024 Benzinga Sports Business Titans event, Sims is a former NFL player with the Lions and Seattle Seahawks. 
Sims today is an entrepreneur as the co-founder of Locker Room Consulting and <a href="https://www.benzinga.com/markets/cannabis/23/06/32770056/former-detroit-lions-calvin-johnson-rob-sims-visit-their-cannabis-company-in-niles-michigan">co-founder of cannabis company</a> Primitiv Group. The name for Primitiv is based on the idea that plants have been used for thousands of years for medicinal purposes.
Calvin Johnson: One of the most well-known Lions players of recent decades, former wide receiver Johnson was known to fans as "Megatron." Johnson retired from the NFL after the 2015 season, playing nine years with the Lions. 
Johnson has gone <a href="https://www.benzinga.com/markets/cannabis/22/09/28874483/exclusive-former-nfl-and-nba-players-admit-to-smoking-pot-to-help-with-pain">on to be a co-founder of </a>Locker Room Consulting and Primitiv Group with Sims.
Gosder Cherilus: A former teammate of Sims and Johnson while with the Lions, Cherilus is also involved with Primitiv as <a href="https://www.benzinga.com/markets/cannabis/24/03/37797148/former-nfl-legends-bring-top-cannabis-strains-to-boston-with-launch-of-primitiv">the co-founder of</a> Primitiv Group Boston, a cannabis company focused on relaxation, rejuvenation and holistic wellness. &nbsp;
Barry Sanders: Considered one of the best Lions players of all time and an NFL Hall of Famer, Sanders needs no introduction. 
Since retiring from the NFL, Sanders has expanded his focus to entrepreneurial efforts that <a href="https://www.barrysanders.com/about.html#:~:text=Life%20After%20Football&amp;text=His%20relationships%20span%20across%20dozens,dealerships%20and%20Lefty's%20Cheesesteak%20stores.">include </a>running the Barry Sanders Nissan dealerships and Lefty's Cheesesteak stores. Sanders also supports several charities including the Scleroderma Research Foundation.
Nate Burleson: The former NFL wide receiver played for the Lions from 2010 to 2013, which came after previous stints with the Seattle Seahawks and Minnesota Vikings. 
Today, Burleson can be <a href="https://www.essence.com/entertainment/nate-burleson-hardest-working-man-in-media/">seen </a>on television around the world as a host of CBS Mornings, The NFL Today and NFL Slimetime. Burleson has also founded several businesses, including those in the clothing sector. 
While a member of the Lions, Burleson founded Lion Blood, a clothing company. Burleson is also a co-founder of suit company Baynes and Baker.
Glover Quin: The former NFL safety played with the Lions from 2013 to 2018 where he played all 16 games in each season, showing off his durability. 
Quin was famous for investing his money while in the NFL, choosing to live off of 30% of his earnings and put the other 70% into savings and investments. 
Quin was an early <a href="https://www.cnbc.com/2016/11/18/how-nfl-player-glover-quin-plans-to-double-his-income-by-investing.html">investor </a>in sports betting companies DraftKings Inc and Flutter Entertainment-owned FanDuel. Other investments of Quin also included Health Warrior, PeerWell and pawTree.  
Jared Goff: One of the newest Lions players and a fan favorite is quarterback Goff, who came to the team via a trade in the 2021 offseason for Matthew Stafford. 
Goff has made several investments during his NFL career including being part of a 2021 <a href="https://www.prnewswire.com/news-releases/underdog-fantasy-announces-fund-raise-in-3-500-000-best-ball-tournament-301282593.html">fundraise </a>for fantasy sports company Underdog Fantasy. Goff was among a group of investors that included Mark Cuban, Kevin Durant, Adam Schefter, The Chainsmokers and more who invested $10 million in the growing company. 
Goff also <a href="https://www.prnewswire.com/news-releases/glosslab-the-hygiene-first-waterless-and-membership-based-nyc-manicure-studio-operator-taps-more-big-name-influencers-and-investors-to-expand-raise-to-over-7m-for-omnichannel-expansion-301284379.html">invested </a>in hygiene-first, waterless, membership-based New York City manicure studio operator GLOSSLAB.
Don&#8217;t miss this unique Benzinga Sports Business Titans event featuring former and current athletes and key voices in the business world. Join Benzinga for the 2024 Sports Business Titans.&nbsp;<a href="https://www.benzinga.com/nfldraft/" target="_blank" rel="noreferrer noopener">Get tickets here</a>.
Read Next: <a href="https://www.benzinga.com/trading-ideas/previews/24/04/38224493/benzinga-sports-business-titans-hear-from-athletes-industry-leaders-at-the-crossroads-of-s">Benzinga Sports Business Titans: Hear From Athletes, Industry Leaders At The Crossroads Of Sports &amp; Entrepreneurship</a>
Photo: Shutterstock

Sports

Detroit Lions Players Invest On The Field And Off: 7 Current, Former Players And Their Investments

FOXA

Jerry Nadler, Joaquin Castro Send Letter To Bob Iger, Lachlan Murdoch, David Zaslav Seeking Info On Proposed Sports Streaming JV; Raises Questions About How It Impacts Access, Competition, Choice

Shares of application software company Autodesk Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADSK#NASDAQ">ADSK</a>) are moving lower after the close on Tuesday following an update from the company on its <a href="https://www.benzinga.com/pressreleases/24/04/n38279870/autodesk-provides-update-on-delayed-form-10-k-filing">delayed quarterly report</a>.
What Happened: Earlier this month, Autodesk announced an internal investigation was being conducted by its board&#8217;s audit committee after information was brought to the attention of management related to the company&#8217;s earnings release in February. 
Autodesk said this week that the committee commenced an internal investigation regarding the company&#8217;s free cash flow and non-GAAP operating margin practices. 
&#8220;The subject of the internal investigation remains the same as previously disclosed, and the Company currently does not believe that any of the matters under investigation affect any previously issued financial statements or the information in the Company&#8217;s earnings release on&nbsp;February 29, 2024. As of today, the investigation is ongoing and all parties continue to work diligently to complete the investigation,&#8221; the company said in a press release.
As a result of the ongoing investigation, Autodesk said it&#8217;s unable to file its annual report for the year ended Jan. 31, 2024, within the 15-day extension period. Accordingly, the company expects to receive a Nasdaq notice informing the company that it is not in compliance with the timely filing requirement for continued listing under Nasdaq rules. 
&#8220;The Company intends to take the necessary steps to regain compliance with Nasdaq&#8217;s listing rules as soon as practicable,&#8221; Autodesk said.
Don&#8217;t Miss: <a href="https://www.benzinga.com/etfs/broad-u-s-equity-etfs/24/04/38278182/powell-delays-fed-rate-cuts-we-need-greater-confidence-in-inflation-2-year-yields-spik">Powell Delays Fed Rate Cuts, Says &#8216;We Need Greater Confidence In Inflation&#8217;: 2-Year Yields Spike To 5%</a>
ADSK Price Action: <a href="https://www.benzinga.com/quote/ADSK">Autodesk shares</a> were down 3.62% Tuesday after-hours at $220, per <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Photo: Courtesy of Autodesk.

-

-

-

-

-

-

-

25% Off Benzinga's Most Powerful Trading Tools

-

-

-

-

-

-

-

Gabelli Growth Innovators ETF (ARCA:GGRW), Trade Ideas